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Bacillus anthracis is a bacterial pathogen of great importance, both historically 
and in the present.  Despite this importance, many questions remain regarding defending 
against its use as a biological weapon, the bacteria’s variation in virulence, and its 
epidemiology in nature.   
Using Etest strips (AB BIODISK, Solna, Sweden) to measure the minimum 
inhibition concentrations (MICs), 25 genetically diverse isolates of B. anthracis were 
tested to determine their susceptibility to seven clinically relevant antimicrobial agents.  
Using the National Committee for Clinical Laboratory Standards (NCCLS) MIC 
breakpoints for staphylococci, three isolates were found to be resistant to penicillin and 
negative for beta-lactamase production.   
From a group of investigations, results indicated B. anthracis virulence is related 
to clonality and the copy numbers per cell of the virulence plasmids, pXO1 and pXO2.  
Isolates were characterized with respect to their plasmid copy number (pXO1/2) using a 
novel method of quantitative PCR and the numbers differ greatly from previous reports.  
Anthrax Vaccine with Adjuvant (AVA) vaccinated guinea pigs were challenged with 20 
B. anthracis strains representative of worldwide genetic diversity.  A virulence model 
was constructed by combining the survival, plasmid copy number, and genotyping (based 
on multilocus variable number tandem repeat analysis typing) data of each isolate.  The 
model obtained was validated using a randomly chosen set of 12 B. anthracis isolates and 
verified model robustness.   
 ix
 x
Two carcass disposal methods, incineration and burial, are recommended to 
decrease or prevent environmental spore contamination.  The extent of contamination 
from an anthrax carcass is almost totally unknown in either method of disposal.  Studies 
of environmental contamination by spores of B. anthracis from infected carcasses have 
only recently been possible because of new technologies.  A method utilizing real-time 
quantitative PCR was developed to quantitate B. anthracis in environmental samples.  
Absolute quantitation was made possible by the use of clones.  This method has allowed 
the evaluation of the environmental contamination by the different carcass disposal 
methods and by scavenging of the carcass.  The results support the complete burning of a 
carcass soon after death as the method choice to decrease environmental contamination 





1.1.  Background 
Anthrax is an acute bacterial disease of primarily herbivores, which is 
transmissible to humans.  The etiologic agent, Bacillus anthracis, is a gram-positive 
spore forming rod shaped bacterium.  Animals become infected by ingesting spores or 
possibly by being bitten by flies that have fed on an infected animal or carcass (7).  
Infected animals are usually found dead as death can occur within 24 hours. (27). 
Anthrax can be found worldwide affecting wildlife, livestock, and humans.  
During epidemics in 1959/60 and 1970 in the Kruger National Park, South Africa, 
anthrax deaths numbered in the thousands (4).  Livestock cases are known to contribute 
to human cases through the cutaneous gastrointestinal and inhalation route.  In 2000, the 
first gastrointestinal cases were reported in the United States after the family ate beef 
from an infected carcass (5).   
In North America in the year 2000, 413 livestock cases were confirmed and in the 
year 2001, 795 (Table 1.1).  For every confirmed anthrax case, it is estimated that at least 
five cases go unreported.  Though an effective vaccine for anthrax does exist and is 
obtainable through a veterinarian, it is often not used until an epidemic occurs.  Vaccine 
complacency seems to arise after three to five years of vaccine use.   
Although environmental contamination with B. anthracis spores occurs because 
of wildlife and domestic livestock cases, the degree or level of contamination from each 
case is unknown.  Anthrax spores are known to persist in the environment for years and 
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are resistant to environmental factors (19).  Spores may be found in soil contaminated by 
diseased animals or in diseased animal products such as hair, wool, hides, and bones (2, 
12).  Very little research has been done on anthrax spore survival under natural 
conditions. 
 
Table 1.1 Reported livestock deaths in North America for the years 2000 and 2001 
Location Reported Anthrax Livestock Deaths 
 Year 2000 Year 2001 
WBNP, Canada 105 83 
Alberta, Canada 0 12 
Hook Lake, Canada 0 11 
Manitoba, Canada 30 9 
Nevada 83 0 
N. Dakota 150 5 
S. Dakota 15 11 
Minnesota 25 88 
Texas 0 555 
California 0 21 
Cuidad Acuna, Mexico   5 0 
Total 413 795 
 
To prevent or decrease the number of spores contaminating an area, several 
methods of carcass disposal have been suggested and utilized.  These methods, including 
incineration, burial, or rendering of the carcass, are recommended with no scientific data 
to back them.  Once a site becomes seeded with spores, the disease becomes enzootic or 
at a constant risk of a persistent series of outbreaks, and sporadic occurrences of the 
disease occur in susceptible animals (26).  
A search of the literature shows little work has been done to ascertain the level of 
contamination from a carcass regardless of the manner of carcass disposal.  Spores are 
known to survive in the environment for years (19).  The worldwide distribution of 
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anthrax and the difficulty encountered in combating it is the result of the marvelous 
tenacity of the anthrax spore (17).  Spores prepared by Pasteur in 1888 were found to be 
viable 68 years later.  Bones recovered in the Kruger National Park and estimated by 
carbon dating to be 200±50 years old are reported to have yielded B. anthracis on culture 
(4).  Recent studies on the ecology of anthrax have reported a correlation between the 
disease and specific soil factors, such as alkaline pH, high moisture, and high organic 
content (16, 23, 24).  Review of the properties of spores of B. anthracis suggests that the 
specific soil factors linked to epidemic areas reflect important environmental conditions 
that aid the anthrax spores in causing epidemics (6).  The Office International Des 
Epizooties (OIE) and World Health Organization (WHO) Anthrax Guidelines 
recommend incineration of infected carcasses as the most desirable method of disposal 
followed by rendering and then by deep burial of the carcass after covering it with 
quicklime (1, 15, 20).  Nothing definitive exists in the literature quantifying or comparing 
environmental contamination by carcass disposal methods. 
1.2.  Significance of the Work 
The 2000 and 2001 North American epidemics raised many questions.  Questions 
about how to treat, vaccinate, quarantine, and dispose of the carcasses were asked by 
everyone from the farm hand to the veterinarian and the department of public health.  
Treatment, vaccination, and quarantine were handled by the attending veterinarian in 
collaboration with the responsible public health departments.  However, there was still 
the question of carcass disposal, which is an interesting dilemma.   
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 Incineration is thought to be the best way to dispose of the carcass and reduce or 
eliminate contamination by the anthrax spores.  However, there exist many problems with 
the incineration of carcasses.  Most cases occur in July and August in geographical areas 
that are very dry and have a high fire risk.  The labor and materials to burn a 2000-pound 
carcass can be prohibitive, especially if there are several deaths.   
 Burial is another option that is suggested especially for high-risk fire areas.  Also 
prior to backfilling, ‘experts’ suggests that quicklime be poured over the carcasses.  Yet 
again burial raises many questions regarding how, where, and what to bury.  No 
guidelines exist on how deep to bury a carcass and how much quicklime should be 
applied, though suggestions and opinions abound.   
 C.D. Stein first suggested quicklime for use in the 1950s though no reason was 
given (18).  Recently, it has been proven that more cases occur in calcium rich soil, and 
as quicklime is a calcium based agent there seems to be no logic supporting this 
suggestion (16).  High levels of calcium in the soil may buffer the spores’ supply of 
calcium and help maintain the spores viability in the environment for longer periods of 
time, thereby increasing their chances of coming into contact with and successfully 
infecting new hosts (14, 16).   
 Also questions regarding single or group burial are numerous.  The burial of each 
carcass where it lay would be the logical choice, but, if there are several cases, group 
burial may be more appropriate.  Group burial presents its own problems with 
transportation of carcasses and contamination.   
 4
 In some areas where anthrax occurs, neither burning nor burial is a viable option.  
WBNP is a prime example of such an area as their cases are usually found by fire spotters 
flying over the park.  The carcasses are usually found in remote areas inaccessible except 
by helicopter or all terrain vehicles.  Getting the equipment necessary for the burial of a 
two-ton bull buffalo carcass into these areas is impossible.   
 Unless carcasses are found and disposed of quickly, scavenging occurs from 
buzzards, canines, felines, and other wildlife.  Scavenging should be kept to a minimum 
as the scavengers help contaminate the environment.  Scavengers open the carcass, which 
allows more sporulation to occur by releasing the vegetative organism from the acidic 
environment of the decaying carcass, thereby, enabling it to sporulate.  Scavengers are 
not as susceptible to anthrax as herbivores; hence; after eating the diseased carcass spread 
spores in their feces.   
 Public health departments and liable parties are interested in environmental 
contamination not just for the possible re-infection of livestock but also for liability and 
safety reasons.  Many acres of pastureland are fast becoming urban ranchettes, and some 
of this pastureland is known as an anthrax area.  They need to know about contamination 
for risk assessment purposes.  They want to know the risk of building homes and 
apartments in areas where anthrax infected carcasses have been disposed and the risk of 
human infection in these areas.   
 These arguments lead to the question of what is the best disposal method of 
anthrax carcasses and how much contamination can be expected utilizing each method.  
The answers will provide scientific data on which to base a decision.   
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 The virulence of B. anthracis is associated with two megaplasmids, and isolates 
lacking either plasmid are either avirulent or significantly attenuated.  Plasmid pXO2 (60 
MDa) carries genes required for the synthesis of an antiphagocytic poly-D-glutamic acid 
capsule (8, 10, 13, 21, 22, 25).  The 110-MDa plasmid pXO1 is required for synthesis of 
the anthrax toxin proteins, edema factor (EF), lethal factor (LF), and protective antigen 
(PA) (21).  These proteins act in binary combinations to produce the two anthrax toxins: 
edema toxin (a protective antigen and edema factor) and lethal toxin (a protective antigen 
and lethal factor) (11).  Despite the important roles of pXO1 and pXO2 in B. anthracis 
virulence, it has always been assumed that each plasmid is represented once in a bacterial 
cell.   
 The original scope of this thesis was the environmental contamination posed by 
anthrax carcass disposal.  During the controlled studies and preparation of the 5’ nuclease 
assay it was discovered that plasmid to chromosome ratio was 1:1:1.  This discovery led 
to a study to quantitate the number of plasmids per bacteria.   
 The bioterrorism events in the Northeast United States in October 2001 also 
changed the scope of this work, as the event involved the mailing of anthrax spores.  The 
first cases of inhalation and cutaneous anthrax resulting from the intentional release of B. 
anthracis were seen with this event (3, 9).  This attack offered a tragic proof of principle 
of the danger of B. anthracis and has spurred numerous efforts by the biological 
community to improve forensics and medical countermeasures against the bacterium.  
My contribution to the immediate threat was an antimicrobial panel against 25 
geographically and genetically diverse B. anthracis isolates to assess minimum inhibitory 
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concentrations.  This panel consisted of penicillin, cephalexin, cefaclor, tobramycin, 
doxycycline, ciprofloxacin, and cefuroxime.   
1.3. Hypotheses 
1. A difference in antimicrobial minimum inhibitory concentrations (MICs) 
exists based on the genotype of B. anthracis isolates  
2. The chromosome and plasmid quantity of a vegetative B. anthracis cell is 
dependent on genotype and affects an isolates’ virulence.   
3. The burning of anthrax infected carcasses contributes the least to the 
environmental contamination by B. anthracis spores.   
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ANTIMICROBIAL SUSCEPTIBILITIES OF DIVERSE  
BACILLUS ANTHRACIS ISOLATES* 
 
2.1. Introduction 
The etiologic agent of anthrax, Bacillus anthracis, is an acute disease of primarily 
herbivores, which is transmissible to humans.  Susceptible animals are primarily infected 
by the spores formed by the vegetative state of the bacteria.  Spores may be found in soil 
contaminated by diseased animals or in diseased animal products such as hair, wool, 
hides, and bones.  The importance of treatment of the disease in humans has been 
underscored by the bioterrorism events of October 2001 in the United States.  
Ciprofloxacin was the antimicrobial of choice for prophylactic treatment after exposure 
to the spores of B. anthracis that were used in the bioterrorism events.  Penicillin, 
traditionally the drug of choice for treatment, is still recommended in other parts of the 
world despite reports of penicillin-resistance (3,4).  The Centers for Disease Control has 
recommended ciprofloxacin, penicillin, and doxycycline for the treatment of human 
anthrax and for use as a prophylactic measure prior to and during the October event (2).  
In the past streptomycin, penicillin, gentamicin, and chloramphenicol have also been 
recommended (7).   
Other articles have been written concerning B. anthracis and antimicrobial 
susceptibilities, two over ten years ago and one within the past year.  The first paper in  
 
* Reprinted by permission of Antimicrobials Agents and Chemotherapy 
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1990 by Lightfoot et al. determined the antimicrobial susceptibility of 70 isolates 
of B anthracis against penicillin, amoxycillin, cefuroxime, gentamicin, streptomycin, 
erythromycin, tretracycline, chloramphenicol, and ciprofloxacin by agar dilution (6).  
Penicillin resistance and beta-lactamase production was noted in two isolates.  This paper 
was quickly followed in 1991 by Doganay and Aydin (3).  They tested 22 B. anthracis 
isolates against 27 antimicrobial agents by agar dilution and reported 19 isolates showed 
resistance to the five 3rd generation cephalosporins tested.  The isolates were shown to be 
sensitive to the other antimicrobials tested.  These two papers were very basic in their 
approach and reporting.  The latest paper, Mohammad et al, tested 65 isolates with nine 
antimicrobial agents using the National Committee for Clinical Laboratory Standards 
(NCCLS) broth microdilution method.(7).  The results obtained from 50 of the isolates 
were compared to the Etest strips.  One isolate was penicillin resistant and no statistically 
significant difference was found between the broth microdilution, and Etest results.   
The two earlier papers distinguished between sensitive and resistant in regards to 
the MIC noted for each isolate(3,6).  Unfortunately, no basis is given, such as what 
standard they used for these designations.  The Mohammed et al. paper used the NCCLS 
breakpoints for Staphylococcus, which we have also chosen to use to discriminate 
between sensitive (S), intermediate (I), and resistant (R).  According to the NCCLS 
literature, studies for Bacillus spp. are not yet adequate to develop reproducible, 
definitive standards to interpret results (8).  The infections caused by Staphylococcus spp. 
are very similar to the infections caused by B. anthracis.  In addition, the distributions of 
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the aforementioned antimicrobial data are in line with the Staphylococcus MIC 
breakpoints for antimicrobials used in this study.   
 In this study, we examined 25 genetically diverse isolates of B. anthracis to 
determine their susceptibility to seven clinically relevant antimicrobial agents.  Etest 
strips (AB BIODISK, Solna, Sweden) were used to measure the MICs of the isolates.   
2.2. Materials and Methods 
2.2.1. Selection of Isolates 
A total of 25 isolates diverse in time, space, and genotype were used in this study (Table 
2.1).  These 25 isolates are a representative subset of 89 distinct genotypes characterized 
by multiple locus variable number tandem repeat analysis (5).   
2.2.2. Study Design 
MICs of seven antimicrobial agents-penicillin, cephalexin, cefaclor, tobramycin, 
doxycycline, ciprofloxacin, and cefuroxime-were determined, using the Etest (AB 
BIODISK Solna, Sweden) methodology described elsewhere (1).  Tryptic soy agar plates 
containing 5% sheep blood (Remel) were inoculated with a swab taken from a colony 
suspension equal to that of a 0.5 McFarland standard.  One Etest strip was placed per 
plate after ten minutes.  Quality control was assessed using Staphylococcus aureaus 
ATCC 29213.  The plates were incubated overnight at 37oC and the plates were read at 
16 and 24 hours.  This was repeated three times for each isolate.  
2.2.3. Beta Lactamase Activity 
Beta-lactamase activity of each isolate was determined with the use of nitrocefin 
disks (BBL), which utilizes a chromogenic cephalosporin.  A drop of sterilized water was 
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applied to the disk, and then with a loop, a colony was removed from the agar plate and 
applied to the disk.  The inoculum was taken from an overnight TSA plate for each 
isolate.  A positive reaction was denoted by the formation of a pink or red color.  The 
reactions were held for one hour to confirm negative results.   
 
Table 2.1. B. anthracis isolates used by genotype and cluster 
Genotype # Cluster Country State/Location Source Year isolated 
3 A1a Canada unknown bovine 1974 
10 A1a USA South Dakota bovine 1996 
15 A1a Poland Krakow bovine 1962 
20 A1a Italy Campania ovine 1994 
23 A1b Turkey Yozgat human 1991 
25 A1b USA Florida bovine 1937 
28 A1b Turkey Sivas human 1984 
29 A2 Pakistan unknown ovine 1978 
30 A3a Zambia Mongu bovine 1992 
34 A3a South Korea Kyungjoo human 1994 
35 A3a Namibia Etosha Nat'l Park zebra 1993 
38 A3a Germany Giessen porcine 1971 
41 A3a Turkey Sivas human 1985 
45 A3a Argentina Buenos Aires bovine 1980 
51 A3a USA Maryland bovine 1939 
55 A3a Australia Queensland bovine 1994 
57 A3b China Changping bovine unknown 
62 A3b USA(Ames) Texas bovine 1981 
67 A3a South Africa Kruger Nat’l Park Kudu 1993 
68 A3d USA Ohio human 1968 
69 A4 Pakistan unknown wool 1976 
77 A4 UK (Vollum) S. Oxfordshire bovine 1937 
80 B1 France unknown bovine 1997 
85 B2 Mozambique Maputo porcine 1944 




The MIC results are summarized in Table 2.2.  Using the Staphylococcus MIC 
breakpoints all isolates were susceptible to the antimicrobials except for cefuroxime and 
penicillin.   
Only one isolate, GT 69, was sensitive, five isolates (GT’s 23, 28, 34, 55, 77) 
were resistant, and the remaining 19 were categorized as intermediate to cefuroxime.  
The MIC90 was 32 µg/ml, which is considered the breakpoint for resistance.  The range 
for cefuroxime was wide, from 6 – 48 µg/ml.     
Of the three recommended antimicrobials for the treatment of anthrax-
ciprofloxacin and doxycycline exhibited potent activity against the B. anthracis isolates.  
Twenty-two of the isolates were susceptible to penicillin and three (GT’s 20, 68, 85) were 
classified as resistant.  None of the isolates examined showed any beta-lactamase activity.  
Ciprofloxacin, the drug-of-choice, had an MIC range of 0.032 to 0.38 µg/ml with a MIC 
at which 90% of the isolates tested are inhibited (MIC90) of 0.094 µg/ml.  This was the 
same as the MIC50 and was the most active agent tested.  All of the isolates were 
susceptible to doxycycline and the other antimicrobials-cephalexin, cefaclor, and 
tobramycin.  
2.4. Discussion 
In this study, we have examined a spatially, temporally, and genetically diverse 
group of B. anthracis isolates for susceptibility to seven clinically relevant 
antimicrobials.  This is the first report to use confirmed genetically diverse field isolates 
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(5).  Lightfoot et al. used 70 isolates, 33 of which were considered by the authors to be 
unrelated(6).  Doganay and Aydin used 22 isolates collected from the same region in 
Table 2.2. MIC50s and MIC90s with antimicrobial susceptibilities of 25 B. anthracis 
isolates. 
  MIC (µg/ml)   Categorical interpretation   
        # of isolatesa  Staphylococcal breakpoints (µg/ml)b
AntimicrobialRange 50% 90%   S I R S I R 
Cefaclor 0.125 - 0.75 0.38 1.65  25   ≤ 8 16 ≥ 32 
Cefuroxime 6 - 48 21.33 32  1 19 5 ≤ 8 16 ≥ 32 
Cephalexin 0.38 - 2 1.5 1.5  25   ≤ 8 16 ≥ 32 
Ciprofloxacin 0.032 - 0.38 0.094 0.094 25   ≤ 1 2 ≥ 4 
Doxycycline 0.094 - 0.38 0.23 0.34  25   ≤ 4 8 ≥ 16 
Penicillin <0.016 - 0.50.042 0.236 22  3 ≤ 0.12  ≥ 0.25 
Tobramycin 0.25 - 1.5 0.75 0.97  25   ≤ 4 8 ≥ 16 
a S – susceptible; I – intermediate; R – resistant 
b NCCLS M100-S12 
Turkey within a period of seven years (3).  The most recent paper, Mohammed et al., 
used 50 historical isolates and 15 recent isolates (7).  The 50 historical isolates collected 
between 1937 and 1997 were selected as representatives of temporally and spatially 
diverse strains.  Together these studies have utilized 182 isolates to test antimicrobial 
susceptibilities.  Unfortunately, the detailed isolate information from previous studies 
could not be obtained and therefore no correlations or comparisons can be made, 
genetically, spatially, or temporally.   
 Cefuroxime is a 3rd generation cephalosporin and is reported to be effective 
against gram-positive bacteria.  The older studies showed a high rate of resistance with 
cefuroxime, though the MIC90s were lower in this study.  The MIC90 for the other studies 
was 64 µg/ml and for this study, it was 32 µg/ml.  This could be an artifact of the 
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methodologies or a true difference in the isolates, but in any case, the reason for this 
resistance is unknown and the mechanism of the resistance needs to be investigated 
further.   
Penicillin and ciprofloxacin were also listed in all studies and all showed good 
activity against the isolates of B. anthracis.  Differences in the MIC90s are noted between 
the reports.   
Penicillin resistance was reported in two of the other studies.  Lightfoot et al. 
reported resistance, MIC >0.25 µg/ml, in two isolates which originated from the same 
fatal case, and Mohammed et al. reported three resistant isolates including the same 
isolate from the Lightfoot et al. study(6,7).  Using the Staphylococcus breakpoints, our 
study demonstrated three resistant isolates.  These isolates were tested for beta-lactamase 
production and found to be non-producers as were all the isolates.  Since the highest 
concentration was within a doubling dilution of the 0.25 µg/ml it is possible that the 
Staphylococcus breakpoints are not appropriate for comparison in bacillus species.  There 
could be other explanations for this observation.  Strains of B. licheniformis have been 
shown to produce large amounts of a beta-lactamase yet be sensitive to penicillin (9).  In 
another study, a strain was shown to be highly susceptible to penicillin and still actively 
produce a beta-lactamase (10).  Penicillin resistance in Bacillus spp. is an area that needs 
more research than a cursory susceptibility panel every few years.   
Ciprofloxacin, doxycycline and the remaining antimicrobial agents, cefaclor, 
cephalexin, and tobramycin, showed all isolates tested highly susceptible.  This was in 
agreement with the other studies that tested the corresponding antimicrobial agent.   
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Now that a reliable genotyping system is available, more genotypes should be 
tested against these and other antimicrobials to verify the trends noted here and in other 
studies.  Beta-lactamase production or non-production should not be considered as an 
alternative for testing penicillin resistance.  Hopefully this study will contribute to the 
impetus for a more thorough study into beta-lactamase production and Bacillus spp.  
Continued surveillance of B. anthracis field isolates is recommended to monitor 
antimicrobial susceptibility.   
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CHAPTER THREE 
BACILLUS ANTHRACIS VIRULENCE IN AVA VACCINATED GUINEA PIGS IS 
LINKED TO PLASMID QUANTITIES AND CLONALITY 
 
3.1. Introduction 
The etiologic agent of anthrax, Bacillus anthracis, is a gram positive, rod-shaped, 
spore forming bacterium.  The disease primarily affects ungulate herbivores, occasionally 
carnivores, and less frequently humans (29).  Anthrax is a disease well documented 
throughout human history with suggestive reports in the Bible and Sanskrit manuscripts 
(5).  Koch, Pasteur, and others revolutionized the field of microbiology with their studies 
using B. anthracis as a model organism (27).  Though anthrax has not been eradicated, 
the development of effective animal and human vaccines has reduced its importance for 
humans and animals in developed countries over the last century.  Recently, however, 
anthrax research has become increasingly important due to this pathogen’s central role in 
biological warfare and biological terrorism (14).  The importance of the disease in 
humans has been underscored by the bioterrorism events of October 2001 in the United 
States.  Therefore, the need for basic techniques that are rapid and reliable, yet exhibit 
high specificity have taken on great importance in the development of detection assays. 
Identification and detection systems based on real-time quantitative PCR (QPCR) 
have been described for several bacteria including B. anthracis (1, 2, 13, 23).  These 
techniques are easy to design, simple to carry out and are commonly applied to monitor 
and detect the microbial status of sample specimens.  With proper design and careful 
application, diagnostic quantitative PCR systems can be applied to reliably estimate and 
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in this case absolutely enumerate target organisms as well as nucleic acid elements within 
those organisms, such as plasmids (21).   
The virulence of B. anthracis has been associated with two megaplasmids, pXO1 
and pXO2 (29)  Plasmid pXO2 (60 MDa) carries the genes required for synthesis of an 
antiphagocytic poly-D-glutamic acid capsule facilitating host immune system evasion (9, 
16, 22, 30, 31, 34).  The 110-MDa plasmid pXO1 is required for synthesis of the three 
anthrax toxin proteins, edema factor (EF), lethal factor (LF), and protective antigen (PA) 
(30).  These proteins act in binary combinations to produce the two anthrax toxins: edema 
toxin (PA and EF) and lethal toxin (PA and LF) (17).  Although the role of capsule and 
toxin in disease pathogenesis have been well characterized, copy numbers of these 
plasmids have not been investigated (7, 18).  Recently, a study has been published 
alluding to the copy number of each plasmid per cell of the ‘Ames’ isolate of B. anthracis 
(26).  While differences have been observed between the virulence of various isolates of 
B. anthracis, only a portion of these can be attributed to plasmid related effects (34). 
Previous studies have shown that the virulence of B. anthracis can vary between 
isolates or strains (6, 8, 20).  Some variation in virulence can be related to the presence or 
absence of the plasmids.  Isolates lacking either the pX01 or pX02 plasmid are 
considered either avirulent or significantly attenuated (24, 32).  However, this does not 
explain the variation in virulence observed in studies comparing fully virulent isolates 
such as the Ames and Vollum 1B strains (11, 12)  Explanations for these differences in 
virulence have never been fully substantiated.  Possible mechanisms responsible for the 
modulation of virulence exist including copy number of plasmids per cell, transcription 
regulation of the anthrax toxins and capsule, and additional variation may be mediated by 
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generation time and germination efficiency.  These factors are likely associated with 
mutations that could be clonally heritable. 
In this study, we have shown that B. anthracis virulence is related to clonality and 
pXO1 and pXO2 copy number.  We chose 20 genetically diverse B. anthracis isolates as 
defined by the multi-locus VNTR analysis (MLVA) (89 distinct genotypes and seven 
major clusters) and performed survival trials in guinea pigs vaccinated with the current 
licensed U.S. human vaccine, anthrax vaccine adsorbed (AVA).  Absolute quantitative 
PCR analysis was used to determine the plasmid copy number present per cell (pXO1, 
pXO2) for each of the isolates.  Our model describing the virulence of B. anthracis 
isolates in AVA vaccinated guinea pigs using MLVA cluster association, clonality, and 
plasmid copy number was then verified using a randomly chosen group of 12 isolates. 
3.2. Materials and Methods 
3.2.1. Bacterial Isolates 
A total of 36 isolates of B. anthracis were included in this study (Table 3.1).  All of 
these isolates have been previously genotyped using multi-locus VNTR analysis (MLVA) 
(Keim).  Initially, twenty isolates were chosen for animal challenge studies and plasmid 
copy number characterization based upon their representation of genetic diversity from a 
worldwide collection.  Genetic diversity was determined by MLVA cluster assignment 
and was based upon genotypic allele patterns described previously for eight VNTR loci 
(15).  The isolates used in this study are representative of all seven major MLVA clusters.  
Twelve isolates were chosen at random from the worldwide collection that were 
previously genetically characterized using MLVA.  
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Table 3.1.  B. anthracis isolates used by country and cluster with the survival percentage 
of AVA vaccinated guinea pigs and the calculated number of plasmids, pXO1 and pXO2.  
Ratio of plasmid to chromosome is in parentheses.   
Id Country Cluster % Survival pXO1 (rpXO1) pXO2 (rpXO2) 
Model Isolate Set         
1 China A3b 0 185 (30.9) 9 (1.5)
2 Australia A3a 0 121 (20.2) 32 (5.4)
3 Namibia A3a 19 242 (40.3) 5 (0.9)
4 Ames A3b 38 65 (10.8) 2 (0.3)
5 Germany A3a 25 113 (18.9) 5 (0.9)
6 Turkey A3a 31 131 (21.8) 11 (1.8)
7 France B2 31 243 (40.5) 4 (0.6)
8 Turkey A1b 38 236 (39.4) 27 (4.5)
9 Pakistan A2 38 120 (20.0) 1 (0.2)
10 South Africa B1 44 66 (11.0) 2 (0.4)
11 Zambia A3a 44 242 (40.4) 15 (2.5)
12 Turkey A1b 44 172 (28.7) 6 (1.0)
13 USA A3a 44 109 (18.1) 4 (0.7)
14 South Africa A3b 50 212 (35.3) 16 (2.6)
15 Argentina A3a 50 104 (17.4) 7 (1.2)
16 Mozambique B1 75 95 (15.9) 1 (0.2)
17 Canada A1a 69 24 (40.5) 18 (3.0)
18 USA A1a 69 128 (21.4) 5 (0.8)
19 Pakistan A4 75 191 (31.9) 14 (2.3)
20 Vollum A4 94 69 (11.5) 10 (1.6)
Test Isolate Set      
A Indonesia A4 13 44.4 (7.4) 4 (0.6)
B South Korea A3a 19 62 (10.4) 3 (0.5)
C USA A3a 19 89 (14.8) 3 (0.5)
D South Africa A4 25 94 (15.6) 11 (1.9)
E India A3a 25 33 (5.5) 2 (0.4)
F USA A3b 31 44 (7.3) 2 (0.4)
G Mozambique B1 44 86 (14.4) 10 (1.6)
H Norway B1 44 218 (36.3) 1 (0.2)
I Croatia B1 44 49 (8.2) 3 (0.5)
J Canada A1a 50 83 (13.9) 5 (0.9)
K USA A1a 50 65 (10.8) 4 (0.7)
L USA A1a 56 115 (19.2) 9 (1.5)
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3.2.2. DNA Preparation 
DNA from each isolate was obtained by heat lysis of a single colony.  The isolates 
were streaked onto blood agar plates and then incubated at 37°C overnight.  A single 
colony from each plate was transferred into a 0.22 µm microcentrifuge tube containing 
200 µl of TE (Tris-HCl [pH 8.0], 1.0 mM EDTA).  The colony was resuspended by 
repetitive pipetting.  The cellular suspension was heated to 95°C for 20 minutes and then 
cooled to room temperature.  Cellular debris and any possible contamination by spores 
were removed by centrifugation at 6,000 x g for 1 min.  Centrifugation was conducted 
inside a biosafety cabinet to contain any aerosols.  The supernatant was then transferred 
to a new tube for storage.  One microliter of the lysate contained sufficient template to 
support a single PCR.   
3.2.3. Oligonucleotide Design of Probes and Primers 
The loci sequences used for the QPCR assay primer and probe development on the 
chromosome, and plasmids pXO1, and pXO2 have previously been published (25).  
Probe and primer sequences (Table 3.2) were designed with the software program Primer 
Express (Perkin-Elmer, Applied Biosystems, Foster City, Calif.) according to the 
manufacturer’s instructions.  The sequence of the probe was selected based on previously 
described criteria: predicted cross-reactivity to B. anthracis; melting temperature of the 
probe at 69°C; lack of predicted dimer formation with corresponding primers and of self-
annealing; a 10°C higher melting temperature of the probe than of the primers; and no 
stretches of identical nucleotides longer than four and no G at the 5’ end of probe (10).  
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The fluorescent reporter dye at the 5’ end of the probe was 6-carboxy-fluorescein (FAM); 
the quencher at the 3’ end was 6-carboxy-tetramethyl-rhodamine (TAMRA).   
Table 3.2.  5’ nuclease assay primers and probes.   
 
Target Primers Sequence (5’-3’) Amplicon 
pXO1 plasmid BApXO1-PR 6FAM-TCGAATTACTAAATCCTGCAGATACACTCCCACC-TAMRA 84 bp 
 BApXO1-FP AATGATCAATTGCGACCGTACTT  
 BApXO1-RP TGCATGCGTCGTTCTTTGATA  
pXO2 plasmid BApXO2-PR 6FAM-TACTGCTTCTGTACGTTGTACCCATGTCGC-TAMRA 131 bp 
 BApXO2-FP TCACCAACCATCGTCATCGT  
 BApXO2-RP CGTTATGTAGCAATCGTATTACCTCTTAT  
Chromosomal BA813-PR 6FAM-AATGCCAGGTTCTATACCGTATCAGCAAGCTATTC-TAMRA 123bp 
 BA813-FP GGAGGGAATACAGCAAACACAGA  
 BA813-RP TGCAACTGATGGGATTTCTTTCT  
3.2.4. Standard for Absolute Quantitation 
Standards for absolute quantitation of each primer/probe grouping (pXO1, pXO2, 
BA813) were prepared as follows.  The PCR amplified fragment obtained with the 
primers for each grouping was cloned using pcDNA3.1/V5-His-TOPO TA and 
transformed into Escherichia coli TOPO10 (Topo TA cloning kit; Invitrogen, NV Leek, 
The Netherlands).  Purification of the plasmid DNA was carried out with a commercial 
plasmid DNA isolation kit (Qiagen, Basel, Switzerland). The DNA concentration was 
determined with a spectrophotometer and was diluted to 1010 templates/5 µl. Dilutions 
were made equivalent to 109, 107, 105, 103, 10 and 1 copy of template per 5 µl.  For 
bidirectional DNA sequencing of the insert, the forward primer and reverse primer were 
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used.  The nucleotide sequence was determined using a fluorescence-based automated 
sequencing system (ABI 377A DNA sequencer) by Microsynth, Balgach, Switzerland. 
The plasmid insert was sequenced to confirm its identity with B. anthracis.  
3.2.5. Test of Detection Limit for 5’ Nuclease Assay 
The detection limit of the QPCR assays for B. anthracis, was determined by making 
serial dilutions of overnight cultures of two isolates, isolate 4 and isolate 17 (Table 3.1), 
suspended in 0.9% NaCl.  The suspension was adjusted to a density corresponding to that 
of a McFarland 1.0 standard and from this serial dilutions were made.  Plate counts from 
each dilution were performed in triplicate on 5% sheep blood agar (Remel).  A total of 
200 µl of culture from each dilution was heat lysed as described above, and 5 µl was used 
for the 5’ nuclease assay. Each test was repeated three times.  
3.2.6. Specificity of the QPCR Assays 
Ten isolates of closely related Bacillus spp. were used to examine the specificity of 
the QPCR assay.  These isolates were B. cereus isolates, ATCC 4381 and ATCC 14579, 
B. subtilis ATCC 6051, B. megaterium ATCC 14580 and four confirmed environmental 
isolates, and two environmental isolates of B. thuringensis.  The environmental isolates 
were confirmed by 16S rRNA sequencing.  
3.2.7.  5’ Nuclease Assay 
Each 25-µl PCR reaction contained 1X TaqMan® Universal PCR Master Mix (Part 
number 4304437, Applied Biosystems), 16 µM each primer, 100 nM fluorogenic probe, 
and 5 µl of template or plasmid standard.  DNA amplification was carried out in 
MicroAmp® Optical 96-well reaction plates (part number N801-0560, Applied 
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Biosystems) sealed with MicroAmp® optical caps (part number N801-0935, Applied 
Biosystems).  The cycling program consists of heating for two minutes at 50oC then 10 
minutes at 95oC followed by a two stage temperature profile of 95oC for 15 seconds and 
60oC degrees for one minute, repeated for 40 cycles.  Amplification, data acquisition, and 
data analysis were carried out with an ABI 7700 Sequence Detector (Applied 
Biosystems).  All 5’ nuclease tests were repeated at least three times for all isolates listed 
in the tables.  
3.2.8.  Vaccination and Challenge 
All data associated was provided by Patricia F. Fellows, USAMRIID, Ft. Detrick, 
Md.  Hartley guinea pigs (Charles River, Wilimington, MA) were vaccinated at 0 and 4 
weeks intramuscularly (i.m.) with 0.5 ml AVA (Bioport, Michigan, etc.).  At 10 weeks 
after the first vaccination, the guinea pigs were challenged i.m. with 10,000 spores of 
virulent B. anthracis.  Survival was noted for 14 days post challenge.   
3.2.9. Absolute Copy Number of Loci, Statistical Analysis and Modeling   
All means, statistical analyses, and modeling were calculated using SPSSTM version 
10.2 software.  The mean absolute copy number of chromosomal loci per cell was 
determined by back calculation using total number of cells in a series of dilution trials 
analyzed with the QPCR assay.  Cross-validation of the mean number of plasmid loci per 
cell was performed using the same methodology.  The mean number of cells per trial 
were determined using most probable number methods and confirmed with direct spore 
counts.  The ratios of plasmid to chromosomal DNA copy were derived by first dividing 
the total estimated copy number of chromosomal loci determined using the QPCR assay 
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by the mean absolute copy number of chromosomal loci per cell (determined above) then, 
dividing the estimated total copies of plasmid loci (for each of the two plasmids 
individually) by the adjusted chromosomal copy number.  
After assembling the data set and calculating the ratios of plasmids to chromosome 
copies, means of the MLVA clusters were estimated concurrent with a one-way analysis 
of variance.  The percent survival of guinea pigs was modeled using a univariate general 
linear model.  The dependent variable, percent survival, was modeled with the two 
covariates ratio of pXO1 to chromosome (rpXO1) and ratio of pXO2 to chromosome 
(rpXO2) and the factor MLVA cluster which had seven levels corresponding to the seven 
major MLVA clusters (15).  The model examined main effects only of the covariates and 
factor.  No interactions were examined for the model.  Parameter estimates and 95% 
confidence intervals were calculated for each covariate, factor level and model intercept 
term.  Statistical significance levels for evaluation of the model were set a priori at alpha 
= 0.05.  Post hoc tests were conducted using the Student-Newman-Keuls method.  
3.3.  Results 
3.3.1.  Specificity and Sensitivity of the 5’ Nuclease Assay   
The three unique primer/probe sets designed for the specific identification and 
target quantification of B. anthracis correctly discriminated all isolates tested (Table 3.2).  
The analytical sensitivity of the QPCR assays was comparable to that of the previously 
described nested PCR (3).  The assay system resolution was sufficient to detect one copy 
of the standard plasmid.  The samples containing no template gave a negative result.  
 
 28
3.3.2.  Chromosome, pXO1, pXO2 Loci per Bacteria and Plasmid Ratios   
The average number of chromosomal loci detected per cell was approximately 6 
for all of the isolates examined. The number of loci detected per cell for each of the 
virulence plasmids, however, varied greatly across isolates, ranging from 33 (isolate E) to 
243 (isolate 7 and 17) for pXO1, and from 1 (isolates 9, 16, and H) to 32 (isolate 2) for 
pXO2.  The plasmid:chromosome loci ratios are listed for each isolate in Table 3.1. 
The mean plasmid:chromosome loci ratios calculated over the seven MLVA 
clusters were significantly different as indicated by the results of an ANOVA (p<0.05) 
(Figure 3.1).  Post hoc tests indicated that for pXO1 there were three overlapping groups.  
Group 1 included MLVA clusters A2, A3a, A3b, A4 and B1.  Group 2 included MLVA 
clusters A1, A2, A3a and A3b.  Group 3 included MLVA clusters A1 and B2.  Post hoc 
tests indicated that for pXO2 there were two overlapping groups.  Group 1 included 
MLVA clusters A2, A3a, A3b, A4, B1 and B2.  Group 2 included MLVA clusters A1, 
A3a, A3b, B1 and B2. 
3.3.3. Vaccination Challenge and Survival 
Survival of the vaccinated guinea pigs ranged from 0 to 94 percent.  The percent 
survival of the vaccinated guinea pigs challenged with each of the isolates used in this 
study, are listed in table 3.1.  The average survival overall was approximately 40%.  The 
average time to death was 5 days for all isolates tested and ranged from 3 to 7 days.  The 
mean percent survival for each MLVA cluster is shown in Figure 3.1.  The results of an 
ANOVA indicated that the means were different (p<0.05).  Post hoc testing showed four 
groups, two of which had overlapping membership (Figure 3.2).  The most virulent 
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MLVA cluster, indicated by lowest survival, had a mean survival of 21.3% (cluster A3b) 
and included an isolate of the Ames strain. 
3.3.4. Model of Virulence 
We analyzed the combined data set of percent survival, ratio of 
plasmid:chromosome (rpXO1 and rpXO2) and MLVA cluster assignment using a general 
linear univariate model.  Overall model statistics indicated that rpXO1 was not a 
significant predictor of survival (p>0.05) but that rpXO2 and MLVA cluster were 
significant (p<0.05 for both).  The parameter estimate obtained for rpXO1 was not 
significant however the estimate obtained for rpXO2 was (rpXO1 = 0.06, p>0.05; rPXO2 
= -1.93, p<0.05).  The magnitude of the parameter estimates obtained for each of the 
seven MLVA clusters indicate a much greater influence on survival outcome than either 
plasmid ratio ranging from 0.00 (A3b) to 75.41 (A4) (Figure 3.2).  As previously 
mentioned, post hoc testing revealed two overlapping and two distinct statistical groups 
(Figure 3.2) indicating that there are potentially as many as five or as few as three 
separate groups among the MLVA clusters.  Graphs of the observed and predicted 
percent survival for both the isolates with which the model was constructed and a test set 
of 12 randomly chosen isolates indicate a good model fit (Figure 3.3).  The raw residual 
values are also shown for each set of predicted and observed comparison. 
Figures 3.1 and 3.2 show a grouping of the MLVA clusters into three distinct 
groups.  The least virulent group, A4, contains isolates from the United States, Norway, 
Europe, and Asia (15).  This group also contains ‘Vollum’ which was used in the UK 
biological warfare program (15).  The middle group is made up of clusters A1 and B1 
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and is of medium virulence.  Clusters A1 and B1 are similar in virulence but are 
geographically diverse.  Isolates in the A1 cluster are found predominantly from Wood 
Bison National Park (Canada), south to Texas in the United States.  Southern African 
isolates make up the majority of the B1 cluster (15).  The most virulent group consists of 
four clusters, A2, A3a, A3b, and B2.  This grouping is also geographically diverse.  B2 is 
found mainly in southern Africa and has been loosely associated with the A cluster (15).  
A3a is associated with isolates from around the world especially Turkey and Namibia.  
































































Bacillus anthracis MLVA Dendrogram (Keim, et al, 2000) 
 
Figure 3.1.  Means of plasmid to chromosome ratios and percent survival of AVA 
vaccinated guinea pigs by MLVA cluster used to build model.   
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Figure 3.2.  MLVA cluster model parameter estimates and 95% confidence intervals. 
3.4.  Discussion 
In this study, we have presented results demonstrating that B. anthracis virulence is 
related to clonality (as indicated by MLVA genotype cluster) and pXO1 and pXO2 copy 
number. By combining data collected from challenge studies of AVA vaccinated guinea 
pigs, pXO1 and pXO2 plasmid copy number with a genetically diverse set of isolates we 
developed a model predictive of virulence.  We then used this model to compare the 
predicted and observed survival of AVA vaccinated guinea pigs when challenged with a 
randomly chosen set of isolates.  It is likely that factors affecting the variation in 
virulence we observed are due to mutations that are heritable and clonally passed on to 
daughter cells.  This could also include a predisposition for stable plasmid copy number 




























































Figure 3.3.  Observed and predicted survival of AVA vaccinated guinea pigs challenged 
with diverse B. anthracis isolates.  Twenty isolates were used to construct the model (A) 




While we can offer no explanation for the association of higher or lower virulence 
with respect to specific MLVA clusters the relationship is plausible from the standpoint 
of mutations and clonality.  Other examples of genetic typing based group differences in 
pathogen virulence have been observed (4).  Further investigation to determine the 
underlying reasons for variation in virulence should center on the genetic differences 
between representative isolates from different MLVA clusters such as A3b and A4, that 
showed extreme differences in mean survival and model parameter estimates.  Although 
rpXO2 was found to be a significant contributor in the virulence model, there was no 
distinct difference in the number of plasmids per cell for clusters A3b and A4; therefore, 
we can conclude that the differences were due to factors other than the number of 
plasmids per cell. 
Our observations have revealed tremendous variation in pXO1 and pXO2 copy 
number per cell using a genetically diverse collection of isolates.  These observations 
were made possible by the use of a new method for molecular detection of B. anthracis 
using QPCR.  Using QPCR, we were able to detect one copy of the standard plasmids for 
the chromosome, pXO1, and pXO2.   A common belief among the research community 
has been that B. anthracis contains only one copy of each plasmid.  Here, using a QPCR 
method, we have shown that there is more than one copy of each plasmid per cell and that 
there is tremendous variation among genetically diverse isolates.  Our results indicate that 
there may be up to 243 copies of pXO1 and 32 copies of pXO2 per cell.  While these 
numbers may seem extreme, this could be appropriate because the longer a cell survives 
the more toxin it can produce.   
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It has long been known that different isolates have exhibited varying levels of virulence 
(11, 19, 28).  The factors responsible for the different levels of virulence in these isolates 
are unknown.  We have shown that the number of pXO2 plasmids in each bacterial cell 
contributes to the level of virulence associated with that isolate.  Although the model that 
we developed indicated that pXO1 copy number does not contribute significantly to 
virulence, it is likely that in an experimental challenge of unvaccinated animals would 
find that the number of copies of pXO1 would also contribute to variations in virulence.  
However, the results of our studies presented here indicate that pXO2 plays a significant 
role in virulence and can contribute to observed variation in virulence.  In the mouse 
model, isolates that only contain pXO2 remained lethal at low doses (33).  Welkos 
showed that the pXO2 plasmid contributes significantly to the virulence of the organism 
(32) and that mutants producing greater amounts of capsule exhibited a higher level of 
virulence than the parental strain.  Figure 3.4 shows an increasing gradation of virulence 
associated with an increase of pXO2.  
Virulence studies of anthrax are an important source of information especially 
considering the organisms use as a bioterror/biowarfare agent.  This study has put 
forward some interesting and significant information concerning virulence of different 
isolates of B. anthracis and the testing of these same isolates in an animal system.  Trends 
in the data with respect to plasmid copy number have revealed clues that will take us into 
the next paradigm of virulence testing.  Hypotheses have been suggested that can now be 
tested due to technological advances in molecular biology techniques.  Additional animal 
studies using unimmunized animals utilizing more representative isolates of all clusters 
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are recommended to validate the model and cluster effect observed in this study.  
Furthermore, validation of the model could lead to its use as a screening tool and 
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 Figure 3.4.  Effect of pXO2:genome ratio on percent survival across MLVA clusters 
holding pXO1:genome ratio constant. 
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CHAPTER FOUR 
BACILLUS ANTHRACIS SPORE CONCENTRATIONS AT  
VARIOUS CARCASS SITES 
 
4.1. Introduction 
 Anthrax, an acute bacterial disease of primarily herbivores, is 
transmissible to humans.  The etiologic agent, Bacillus anthracis, is a gram-positive 
spore forming rod shaped bacterium.  Animals become infected by ingesting spores or 
possibly by being bitten by flies that have fed on an infected animal or carcass (8).  
Infected animals are usually found dead as death can occur within 24 hours. (25). 
It is generally thought that B. anthracis is an obligate pathogen and that little 
propagation occurs in soil (4, 5, 12). With the exception of scavengers, anthrax is almost 
never transmitted directly from victim to victim but is rather ingested by herbivores while 
grazing or browsing. In such a model, the environmental spore reservoir becomes very 
important to the ecology and evolution of this pathogen.  Survival in the soil is crucial for 
initiating subsequent anthrax epidemics.  
Although environmental contamination with B. anthracis spores occurs because 
of wildlife and domestic livestock cases, the degree or level of contamination from each 
case is unknown.  Anthrax spores are known to persist in the environment for years and 
are resistant to environmental factors (20).  Spores may be found in soil contaminated by 
diseased animals or in diseased animal products such as hair, wool, hides, and bones (2).   
To prevent or decrease the number of spores contaminating an area, several 
methods of carcass disposal have been suggested and utilized.  These methods, including 
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incineration, burial, or rendering of the carcass, are recommended with no scientific data 
to back them.  Once a site becomes seeded with spores, the disease becomes enzootic or 
at a constant risk of a persistent series of outbreaks, and sporadic occurrences of the 
disease occur in susceptible animals (24). The Office International Des Epizooties (OIE) 
and World Health Organization (WHO) Anthrax Guidelines recommend incineration of 
infected carcasses as the most desirable method of disposal followed by rendering and 
deep burial of the carcass after covering it with quicklime (1, 14, 21).   
Spores are known to survive in the environment for years (19).  The worldwide 
distribution of anthrax and the difficulty encountered in combating it is because of the 
marvelous tenacity of the anthrax spore (17).  Spores prepared by Pasteur in 1888 were 
found to be viable 68 years later.  Bones recovered in the Kruger National Park and 
estimated by carbon dating to be 200±50 years old are reported to have yielded B. 
anthracis on culture (4).  Recent studies on the ecology of anthrax have reported a 
correlation between the disease and specific soil factors, such as alkaline pH, high 
moisture, and high organic content (16, 22, 23).  Review of the properties of spores of B. 
anthracis suggests that the specific soil factors linked to epidemic areas reflect important 
environmental conditions that aid the anthrax spores in causing epidemics (5).   
A search of the literature shows little work has been done to ascertain the level of 
contamination from a carcass regardless of the manner of carcass disposal, and only three 
studies have been done concerning contamination from anthrax infected carcasses.  
Dragon et al. collected environmental samples from known burial and cremation sties in 
Wood Buffalo National Park and Mackenzie Bison Sanctuary in the Northwest 
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Territories of Canada after several epizootics had occurred in the region over the past ten 
years.  Another study was conducted in the Etosha National Park, Namibia, by Lindeque 
et al (12).  The park leaves all carcasses exposed on the surface therefore, there was not a 
disposal method comparison but they did look at spore levels in soil contaminated by the 
body fluids of animals that had died of anthrax.  The Etosha study also detected B. 
anthracis in scavenger feces and water.   
 Turnbull et al. described a case in North Devon, England, where two 
ponies died in the field in which they had been grazing in 1986 (19).  The ponies were 
disposed of by rendering and an investigation of how they may have become infected led 
to the discovery that a young bull had died of anthrax around 1938 and had been buried 
in the field.  A bacteriological survey of the field in 1991 revealed isolates could be 
recovered from the immediate area which corresponded to the burial site of the bull.  This 
area was surveyed again in 1992 with the same results.  After two unsuccessful efforts at 
chemical disinfection with formalin being pumped into the ground and applied to the 
surface a decision was made to place a concrete cap, 9m X 5m X 20 cm, over the burial 
site to provide a permanent barrier between viable spores and humans or animals.   
The samples obtained for these 3 studies ranged in time from immediately after 
death to 50 years later.  The time between death and sampling for this study ranged from 
two to thirteen months.  The sampling sites where these samples were taken were diverse 
in disposal method and environment.  They included carcasses that had been left exposed 
on the surface to be scavenged and to decay with time, buried, burned and some were a 
combination of these methods.  The environment from which these samples were 
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collected, ranged from the far North to the South, Wood Buffalo National Park (WBNP) 
in the Northwest Territories of Canada; Washoe County, Nevada; and Cuidad Acuna, 
Mexico, directly across the border from Del Rio, Texas.   
Nothing definitive exists in the literature quantifying or comparing environmental 
contamination by carcass disposal methods.  To study the risks of the environmental 
contamination posed by anthrax infected carcass disposal methods, the soil around 
carcasses which had been treated by the different recommended disposal methods was 
sampled.  Utilizing methods to concentrate the B. anthracis spores found in a soil sample 
and extracting the DNA from these spores for identification, it was possible to use 
statistical methods to determine the efficacy of the disposal methods.   
4.2. Materials and Methods 
4.2.1. Site Selection 
 The locations were selected based on the carcass disposal method employed.  
Sampling sites were selected on accessibility and consisted of a confirmed anthrax 
carcass that had been left exposed, buried, and/or burned.  Once the site was selected, a 
sampling area was created.   
4.2.2. Surface Soil Sampling 
 A survey stake was driven into the ground directly over the buried carcass or in 
the center of the sampling area.  Using the stake as the center, a five-meter radius circle 
was marked off using flags.  With the use of a compass, the cardinal directions, north, 
south, east and west, were marked with a red flag at north and pink flags at the other 
directions (Appendix 1).  The boundary of the circle was marked with a different colored 
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flag.  The flags broke the circle into quadrants and five random samples were selected in 
each quadrant by tossing five tennis balls into the quadrant and taking 10 cm core 
samples with a Hoffer soil sampler where each ball had landed.  The approximate 
location of each sample was noted on the data collection diagram with the sample 
number.  Twenty surface samples were collected at each site.  The soil sampler was 
cleaned with a sporacide between sites. 
4.2.3. Deep Core Soil Sampling 
 Burial sites were sampled using a mud auger and the appropriate extensions.  One 
deep core hole was made per buried carcass site.  The soil was collected in the auger, and, 
as the auger would fill with soil, it was removed and the soil collected in a separate 
container and marked with the depth and site information.  Soil collecting continued until 
the buried carcass was reached and tissue was recovered.  The sampling equipment was 
cleaned with a sporacidal solution between sites.   
4.2.4. Spore Concentration Method 
 From each soil sample collected, 4 grams of soil was placed into a 50ml 
centrifuge tube.  To the sample, 30 ml of a wash solution (1.22 gm/ml sucrose, 
0.5%Triton X-100) was added.  The sample was then vortexed and placed on a shaker for 
30 minutes.  The top 3ml was transferred to a tube containing 6 ml of BSA/PBS (bovine 
serum albumin, with phosphate buffered saline, pH 7.4 [PN: P3688 Sigma Chemical 
Company, St. Louis, Mo.]), vortexed and centrifuged (6000 g) for 10 minutes.  The 
supernatant was discarded, 5 ml of 90% ethanol was added to the pellet, vortexed, and 
placed on a shaker for 30 minutes.  The sample was centrifuged (6000 g) for 10 minutes, 
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the supernatant was discarded, and the pellet was resuspended in 1ml of the BSA/PBS 
solution.  Samples were stored at 4oC.   
4.2.5. DNA Extraction Method 
In a 2 ml bead-beater tube (BioSpec Products,Inc., Bartlesville, Okla.) containing 
900 mg of a mixture of glass beads (450 mg each of 425-600 µm and 106 µm and finer 
glass beads [Sigma Chemical Company, St. Louis, Mo., or BioSpec Products,Inc., 
Bartlesville, Okla.]) and 0.5 ml of 2X TENS buffer (1X TENS is 50 mM Tris HCl [pH 
8.0], 20 mM EDTA, 100 mM NaCl, 1% [wt/vol] sodium dodecyl sulfate [SDS]), 0.5 ml 
of liquid product from the spore concentration method was added.  The tubes were 
incubated at 70oC for 30 minutes, removing the samples every 10 minutes to vortex.  
Samples were homogenized for three minutes at 5,000 rpm in a mini-beadbeater-8 cell 
disruptor (catalog no. 693; BioSpec Products,Inc., Bartlesville, Okla.) and were then 
centrifuged at 12,000 X g for 10 min at 4oC to pellet the bead mix. The supernatant 
containing DNA was collected into a 15 ml centrifuge tube and stored on ice.  Under a 
vented safety hood, 1 ml of chloroform:isoamyl alcohol (24:1 volume/volume) was added 
to the 15 ml tube and placed on a tube rocker for 20 minutes, then centrifuged at 7000 X 
g at 4o C for 10 minutes.  The upper aqueous phase of the mixture was transferred to a 
sterile micro-centrifuge tube and Rnase (1 µg/ml or 1:100) was added, inverted by hand 
to mix, and incubated at 37oC for 1 hour.  Under a vented safety hood, an equal volume 
(500 µl) of chloroform:isoamyl alcohol (24:1 volume/volume) was added and the sample 
was placed on a tube rocker for 20 minutes, then centrifuged at 7000 X g at 4o C for 15 
minutes.  The upper aqueous phase of the mixture was transferred to a sterile micro-
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centrifuge tube, and 0.6 volumes of isopropyl alcohol was added, then inverted by hand 
to mix.  The samples were frozen at -20o C from 2 hours to overnight, and the nucleic 
acids were precipitated by centrifugation at 4000 X g for 5 minutes.  The supernatant was 
carefully poured off, and the DNA was washed with 500 µl 70% ethanol and centrifuged 
at 800 X g for five minutes to re-pellet.  The supernatant was carefully poured off, and 
the pellet briefly dried.  The pellet was dissolved in 500 µl sterile 1XTE buffer (10 mM 
Tris pH 7.6, 1 mM EDTA).  Samples were stored at -80oC.   
4.2.6. Control Soil 
 Soil from Falaise lake, Northwest Territories, Canada, was used for a control 
study.  One kilogram of the soil was sterilized by autoclaving at 121oC for 30 minutes on 
the wrapped cycle.  Sterility was verified by mixing 0.1 gm of the sterile soil with 10 ml 
of nutrient broth and incubating at 37oC.  The broth was checked for growth every 24 
hours for three days with no growth noted.  Four grams of sterile soil and unsterile soil 
was spiked with 100, 500, 1000, and 10000 spores of B. anthracis in triplicate.  These 
controls were processed through the spore concentration and DNA extraction methods.  
From the 1 ml liquid product of the spore concentration method, 100 µl was plated on 
sheep blood agar (SBA, [Remel, Inc.]) in triplicate for all samples.  After overnight 
incubation at 37oC, the plates were removed and colonies of B. anthracis were counted 
and recorded.   
4.2.7. Miscellaneous Environmental Samples 
 Samples other than soil were collected in the area of the sampling site.  These 
samples included parts of the carcasses, flies, carnivore scat, and water.  These samples 
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were processed through the spore concentration method.  From the 1 ml liquid product of 
the spore concentration method, 10 µl was plated on SBA.  This was done in triplicate for 
all miscellaneous samples.  After overnight incubation at 37oC, the plates were removed 
and visually inspected for colonies of B. anthracis. All suspect colonies were sub-
cultured onto SBA, and a 5 µl drop of B. anthracis specific gamma phage was applied for 
confirmation.  After overnight incubation, at 37oC the plates were inspected for a clear 
zone where the gamma phage had been applied indicating phage sensitivity.  The gamma 
phage sensitive isolates were sub-cultured onto a nutrient agar slant and were placed in 
the incubator at 37oC for four weeks which allowed for full sporulation and drying of the 
agar, then stored at room temperature.   
4.2.8. Spore Viability 
 Random samples from the WBNP 2000 and Nevada soil samples were selected 
and from the liquid product of the spore concentration method, 10 µl was plated on SBA.  
This was done in triplicate for all selected samples.  After overnight incubation at 37oC, 
the plates were removed and visually inspected for colonies of B. anthracis. All suspect 
colonies were sub-cultured onto SBA, and a 5 µl drop of gamma phage was applied for 
confirmation.  After overnight incubation at 37oC, the plates were inspected for a clear 
zone where the gamma phage had been applied indicating phage sensitivity.  The number 
of positives was recorded.   
4.2.9. Oligonucleotide Design of the Probe and Primers 
PCR primer sequences for loci on the chromosome, plasmids pXO1, and pXO2 
have previously been published (15).  These primers were used as the basis of the primers 
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and probes developed for the TaqMan assays (Table 4.1).  The TaqMan probe and the 
primer sequences were designed with the software program Primer Express (Perkin-
Elmer, Applied Biosystems, Foster City, Calif.) according to the manufacturer’s 
instructions.  The sequence of the probe was selected based on previously described 
criteria (9):  predicted cross-reactivity to B. anthracis, melting temperature of the probe at 
69°C; lack of predicted dimer formation with corresponding primers and of self-
annealing; a 10°C higher melting temperature of the probe than of the primers; and no 
stretches of identical nucleotides longer than four and no G at the 5’ end of probe.  The 
fluorescent reporter dye at the 5’ end of the TaqMan probe was 6-carboxy-fluorescein 
(FAM); the quencher at the 3’ end was 6-carboxy-tetramethyl-rhodamine (TAMRA).   
 
Table 4.1.  5’ nuclease assay primers and probes 
 
Target Primers Sequence (5’-3’) Amplicon  
pXO1 plasmid BApXO1-PR 6FAM-TCGAATTACTAAATCCTGCAGATACACTCCCACC-TAMRA 84 bp 
  BApXO1-FP AATGATCAATTGCGACCGTACTT   
  BApXO1-RP TGCATGCGTCGTTCTTTGATA   
pXO2 plasmid BApXO2-PR 6FAM-TACTGCTTCTGTACGTTGTACCCATGTCGC-TAMRA 131 bp 
  BApXO2-FP TCACCAACCATCGTCATCGT   
  BApXO2-RP CGTTATGTAGCAATCGTATTACCTCTTAT   
Chromosomal  BA813-PR 6FAM-AATGCCAGGTTCTATACCGTATCAGCAAGCTATTC-TAMRA 123bp 
  BA813-FP GGAGGGAATACAGCAAACACAGA   




4.2.10. Plasmid Standard for Absolute Quantitation 
A plasmid standard for absolute quantitation of each primer/probe grouping 
(pXO1, pXO2, BA813) was prepared as follows.  The fragment obtained with the primers 
for each grouping was cloned using pcDNA3.1/V5-His-TOPO TA and transformed into 
Escherichia coli TOPO10 (Topo TA cloning kit; Invitrogen, NV Leek, The Netherlands).  
Purification of the plasmid DNA was carried out with a commercial plasmid DNA 
isolation kit (Qiagen, Basel, Switzerland). The DNA concentration was determined with a 
spectrophotometer and was diluted to 1010 templates/5 µl. Dilutions were made 
equivalent to 109, 107, 105, 103, 10 and 1 copy per 5 µl.  For bidirectional DNA 
sequencing of the insert, the forward primer and reverse primer were used.  The 
nucleotide sequence was determined using a fluorescence-based automated sequencing 
system (ABI 377A DNA sequencer) by Microsynth, Balgach, Switzerland. The plasmid 
insert was sequenced to confirm its identity with B. anthracis. 
4.2.11.  Quantitative PCR Assay 
Each 25-µl Quantitative PCR (QPCR) reaction contained 1X TaqMan® Universal 
PCR Master Mix (Part number 4304437, Applied Biosystems), 16 µM each primer, 100 
nM fluorogenic probe, and 9 µl of template or 5 µl of plasmid standard.  DNA 
amplification was carried out in MicroAmp® Optical 96-well reaction plates (part 
number N801-0560, Applied Biosystems) sealed with MicroAmp® optical caps (part 
number N801-0935, Applied Biosystems).  The cycling program consisted of heating for 
two minutes at 50oC, then 10 minutes at 95oC, followed by a two stage temperature 
profile of 95oC for 15 seconds and 60oC degrees for one minute, repeated for 40 cycles.  
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Amplification, data acquisition, and data analysis were carried out with an ABI 7700 
Sequence Detector (Applied Biosystems).  All QPCR tests were repeated at least four 
times for each sample tested.   
4.2.12. Statistical Analysis 
 All means, statistical analyses, and modeling were calculated using SPSSTM 
version 11.0.1 software.  After assembling the dataset, the means of the QPCR results for 
each sample was calculated.  Descriptive statistics, bivariate correlations, univariate 
general linear models, and linear regression analyses were performed.  Statistical 
significance levels were set a priori at alpha = 0.05.  
4.3. Results 
4.3.1. Site Selection 
 A total of 77 sites were sampled (Table 4.2).  No disposal method was used in 
WBNP; all of the carcasses were left exposed on the surface.  Mixtures of disposal 
methods were utilized in Nevada.  Six of the sites were of single carcasses that had only 
been burned, two sites consisted of one carcass each that had been burned and then 
buried, 14 were buried only, 15 were buried with lime poured over the carcass before 
backfilling and one carcass was limed and left exposed on the surface.  The five cases in 
Mexico were all burned.   
4.3.2. Soil Sampling 
 A total of 1538 surface and 241 burial soil samples were collected and worked 
through the spore concentration and DNA extraction protocols (Table 4.2.).  The overall 
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mean for the surface samples was 1.5 x 107 spores and 2.5 x 107 for the burial samples.  
The difference was not statistically significant (p=0.792).   
 












WBNP 2000 19 388 0 90 
WBNP 2001 15 300 0 0 
Nevada 38 760 241 58 
Cuidad 
Acuna, Mexico 5 100 0 17 
Totals 77 1538 241 165 
4.3.3. Control Soil 
 A comparison of the CFU counts and QPCR results is shown in Figure 4.1.  These 
results revealed a Pearson correlation coefficient of .974, (p<0.05) for the sterile and 
unsterile soil and a linear relationship (r2 = .949).   
4.3.4.  Miscellaneous Environmental Samples 
 Miscellaneous samples were collected from WBNP, Nevada, and Mexico (Table 
4.2).  No isolates were recovered from the 17 miscellaneous samples collected in Mexico, 
possibly because the carcasses were completely burned within hours of finding them.  
The samples collected from the WBNP and Nevada sites revealed many positives, 64.5% 
and 37.5% respectively (Figure 4.2.).  Out of all the samples tested, the scat from both 
locations showed the highest percentage of recovery, 72% from WBNP and 42% from 
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Nevada.  The scat samples were from wolf (Canis lupis) and black bear (Ursus 





















Figure 4.1.  A comparison of B. anthracis CFU’s on sheep blood agar and QPCR 
absolute counts with the number of spores spiked in sterile and unsterile soil.   
 
levels of contamination per recovery plate.  Most of the SBA plates revealed high 
numbers of B. anthracis colonies with low contamination from other bacteria.   
All of the water samples from WBNP and half of the Nevada water samples tested 
positive.  These water samples were taken from near a carcass and within the sampling 
area.   
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 The carcass samples consisted of swabs of body fluids, tissue samples, hair, 
hooves, and bone.  These samples were intimately associated with the carcass, yet the 
















Figure 4.2.  Miscellaneous environmental samples taken from sites in Wood Buffalo 
National Park, Canada, and Nevada. 
 
 
4.3.5. Spore Viability 
 Figure 4.3 is a graphical comparison of the CFU and QPCR results normalized to 
1000 µl.  This 1000 µl is the product of the spore concentration method with four grams 
of soil.  The Pearson correlation coefficient between the CFU’s and QPCR was positive 
(0.326, p=0.017) indicating a linear relationship.  A linear trendline was calculated and 
overlaid for each line on Figure 4.3 to further point out the linear relationship between the 
colony counts and QPCR results.  A linear regression analysis revealed that the lower 
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threshold of sensitivity was 7500, meaning there must be at least 7500 pXO1 copies 
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Figure 4.3.  Comparison of colony forming units on sheep blood agar and quantitative 
PCR.   
 
4.3.6. Test of Detection Limit for Quantitative PCR Assay 
 The analytical sensitivity of the TaqMan PCR was comparable to that of the 
previously described nested PCR (2).  The assay system detected one copy of the 
standard plasmid.  The samples containing no template gave a negative result.  The 
amplification of a plasmid standard dilution over nine 10-fold dilutions showed linearity 




 Research methods have been a limiting factor to the isolation of B. anthracis from 
environmental samples.  Bacteriological studies have been performed on a very small 
scale because of the  difficulty of spore isolation involving environmental samples 
because of contamination by other soil organisms (6, 18).  The spore concentration 
method developed for this study utilized the hydrophobic and specific gravity properties 
of the spore and showed a clear correlation between plate counts and quantification by 
PCR.  This study has shown that large scale environmental bacteriological examination 
for B. anthracis is now possible.  These improved methods have enabled the first 
analyses of carcass sites in regards to environmental contamination, disposal method 
comparison, and decay over time of B. anthracis.   
 The assessment of the environmental contamination by carcasses and scavenging 
was complex.  Scavenging of the carcasses did contribute to the environmental 
contamination with numbers frequently high and potentially able to produce new foci of 
infection (21).  Levels of anthrax spores in scavenger feces depend largely on the state of 
anthrax sporulation in the carcasses as vegetative B. anthracis probably do not survive 
transit through the digestive system of the scavengers (7, 10).   
 Environmental contamination by the carcass was observed by both soil and 
miscellaneous samples.  The miscellaneous samples were surprising as a higher 
percentage of positives were expected since the samples were intimately associated with 
the carcass.  Factors that could have affected the sporulation and the spores is that an 
acidic environment produced by a decaying body inhibits the vegetative bacteria from 
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sporulating (25).  It has been shown that only a small proportion of bacilli released from a 
carcass by hemorrhage, natural and otherwise caused, sporulate successfully.  
Temperature, moisture, and UV radiation are also known to affect sporulation of B. 
anthracis (3, 11, 13).  These factors, along with rain, wind, and snow, could also affect 
the spores over time.   
 Considering these factors, a significant difference was detected (p=0.17) between 






















Figure 4.4.  Difference in QPCR counts over time in Wood Buffalo National Park in the 
years 2000 and 2001.   
 
The samples were taken one year apart at the same sites sampled in 2000.  The time 
between death and sampling also proved to be significant (p=0.13) (Figure 4.5).  This 
decrease in spores over time was also noted at carcass sites in the Etosha National Park.  
The differences seen here address the need to widen the sampling to include sites from 
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historical anthrax areas, present outbreak sites, and a time series over these sites sampling 




















Figure 4.5.  Difference in QPCR counts between time of death and time of sampling.   
 
 When separating the sites by locality within the region, a significant difference 
(p=0.001) was noted (Figure 4.6).  The differences noted here could be caused by many 
factors such as soil, rain, and other environmental factors.  The two regions with the 
highest counts, Lake One Delta and the 91–92 Site, are very different in that the 91-92 
Site localities have not had a known anthrax case since 1992, while the Lake One Delta is 
an area where some of the first cases are found and the last cases in the area were 
reported in 2001.  Another difference between theses locals is the 91-92 Sites are burial 
sites of an unknown number of buried carcasses and the Lake One Delta is a low lying 
area that drains into a lake.  Only surface samples were taken at both locals, and isolates 
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were recovered from both in the range of 1000 per ml.  The reason for the high counts 
associated with the 91-92 Sites is unknown, but speculation could involve the surface 
contamination by the buried carcasses.  A resampling of this burial site including deep 
samples would be informative and may give clues as to where the spores are coming 














































































































Figure 4.6.  Comparison of mean QPCR of samples from localities by region. 
 
 The purpose of this study was to determine if there was a difference in the 
environmental contamination by the different carcass disposal methods, nothing, burned, 
or buried, by themselves or in combination.  Statistically, there was not a difference using 
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the method of disposal and the mean QPCR (p=0.965) in the environmental 
contamination from each disposal method.  A statistically significant difference is seen 
between the method of disposal and the mean CFU per ml (p=0.013).  Burning the 
carcass did prove statistically significant (p=0.044) when compared to leaving the carcass 
exposed with no treatment but was not statistically significant from the other methods of 
burying the carcass with or without lime before backfilling (Figure 4.7).  The p values for 
the other two methods, buried and buried with lime, was 0.05, indicating that they were 
the same as leaving the carcass exposed to the environment.  Figure 4.8 demonstrates the 
reason that no difference was significant between buried, buried with lime, and burned, 




















Figure 4.7.  Mean of the colony forming units per milliliter from the spore extraction 
compared to the method of disposal.   
 A clearer difference between disposal methods would no doubt become evident 
with more sampling.  These samples should be taken over more sites from areas not 
represented here, and, as stated before, time-series sampling would lend more to the 























Figure 4.8.  95% confidence intervals of the CFU per milliliter and the method of carcass 
disposal.   
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CHAPTER FIVE 
GENERAL DISCUSSION AND CONCLUSIONS 
 
5.1. Discussion of the Results 
Three major studies concerning the properties of B. anthracis are discussed in this 
document.  Each study revealed some new and exciting discoveries.  These studies 
also provided information which made us pause and want to ask more questions.  
They also showed how little we know about the antimicrobial susceptibilities, 
lethality, dispersion, and survival of B. anthracis.   
Antimicrobial susceptibility testing for B. anthracis has only previously been 
reported three times (2, 8, 10).  These reports together tested 182 isolates for 
antimicrobial susceptibilities and unfortunately did not include enough detail about 
the isolates to make a comparison except by species.  This study utilized 25 isolates 
of B. anthracis that are diverse in space, time, and genetics, and was reported as such 
in hopes that the results will be more relevant to later studies.   
A comparison of the results between studies did show similarities in 
susceptibilities to most of the antimicrobials tested, such as ciprofloxacin, 
doxycycline, cefaclor, cephalexin and tobramycin.  It was also noted that with 
cefuroxime, a 3rd generation cephalosporin, differences were noted between the 
studies.  The older studies showed a higher rate of resistance than the present study 
which could be a reflection of different methodologies or a difference in the isolates 
used (2, 8).  The methods used in these older studies utilized agar dilution which has 
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been shown to have a high correlation with the E-test method (10, 12).  The 
differences noted are probably because of different isolates, and unless more testing is 
done, this will remain a theory.   
Penicillin resistance was noted in this study and has been reported by other 
investigators (2, 8, 16).   
Beta-lactamase production is a questionable issue with B. anthracis.  Penicillin 
resistant isolates have been found to be non-producers, and penicillin sensitive 
isolates have been shown to actively produce beta-lactamase (13).  A theory is that all 
B. anthracis carry the beta-lactamase gene but expression is suppressed (16).   
The anthrax research community has believed there was only one of each 
plasmid, pXo1 and pXO2, since the discovery of the plasmids in 1985 (6).  With the 
use of new technologies in molecular detection, we have shown that there is more 
than one copy of each plasmid per cell and that there is tremendous variation among 
genetically diverse isolates.  Though the chromosome did not reflect the variation in 
loci seen with the plasmids, the numbers could be appropriate from a biochemical and 
virulence viewpoint.   
An assumption exists that pXO1 contributes the most to the organisms virulence.  
The model we developed indicated that pXO1 copy number does not contribute 
significantly to virulence but that pXO2 plays a major role in virulence and is a 
contributor to the observed variation in virulence.  These results would agree with 
previous studies that showed that mutants producing greater amounts of capsule were 
more virulent (17).   
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Another profound observation from this study was that anthrax virulence is 
related to clonality as indicated by MLVA genotype cluster (7).  The variation in 
virulence we observed are likely caused by mutations that are heritable and clonally 
passed on to daughter cells.  This phenomenon of virulence related clonality has been 
associated with the cause of Rabbit Fever, Francisella tularensis (1, 5, 11).   
Such a large scale study of the environmental contamination caused by a carcass, 
directly and indirectly, has not been attempted before this study.  Studies on a much 
smaller scale have been reported, but none have compared disposal methods (3, 9, 
15).  The study reported here compared carcass that had been left exposed on the 
surface to decompose over time, buried, burned, and some were a combination of 
these.  To accomplish this comparison, unique methods were developed to isolate B. 
anthracis spores and to extract DNA on a large scale.   
This study with its unique methods and samples had to have checks and balances 
to validate the protocols and results.  These consisted of a comparison between CFU 
counts on SBA and the QPCR results, a QPCR detection limit study and spore 
viability.   
The test of the detection limit for the 5’ nuclease assay found the system detected 
one copy of the standard plasmid, and the samples containing no template gave a 
negative result.  This sensitivity was needed for the comparison of the CFU counts to 
the QPCR and the spore viability tests.   
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Spiking sterile and unsterile control soils revealed a clear correlation between the 
CFU counts and the QPCR results.  This gives credibility to the spore’s viability 
found within the field samples and to the study as a whole.   
One of the most surprising results was the finding of no difference between the 
overall means of the surface soil samples (1.5 x 107 spores) and the burial soil 
samples (2.5 x 107 spores).  This could have been caused by the method of 
backfilling, spore movement from the carcass to the surface, or the backfill dirt being 
grossly contaminated.  Other causes could be postulated, but, until more samples are 
collected and analyzed from various burial sites, it seems that burial is a method that 
only disguises the contamination - out of sight, out of mind.   
One of the questions for this study was the extent of environmental contamination 
by scavengers.  These samples were represented by carnivore scat that was collected 
within 25 meters of a carcass or burial site.  Most likely because the carcasses in 
Mexico were completely burned within hours of finding the carcass, no isolates were 
recovered.   
Minimum infectious dose (MID) estimates established by British biological 
warfare work in the early 1940s found that the dose needed to ensure lethal infection 
by the oral route in sheep, horses, and cattle was 5 x 108 spores (16).  Of the 25 scat 
samples collected from WBNP, 18 were positive for viable B. anthracis.  From these 
positive samples, a third produced half of this MID in just four grams.  Since on 
average the scat weighed over 20 grams, scavengers could be a source by potentially 
producing new foci or infection.   
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Only five of the 12 scat samples collected in Nevada were positive and only one 
of these produced enough spores to potentially produce a new focus of infection.  The 
difference to be pointed out here is that the carcasses in WBNP were left exposed to 
be scavenged and the majority of carcasses in Nevada were buried.  In Nevada, the 
one sample that had a high recovery was from a site where the carcass had been left 
exposed on the surface.   
The objective for the soil study was to ascertain which carcass disposal method 
contributed the least to environmental contamination.  Unfortunately the answer to 
this question was not readily apparent from the data.   
No difference between the methods of disposal and environmental contamination 
when comparing the QPCR results was noted, but there was a difference when 
comparing the disposal method with the CFU counts per milliliter.  This difference is 
attributed to the fact that the DNA is still detectable even if the spore or bacteria have 
been rendered non-viable.  This has been demonstrated with autoclaved material 
including B. anthracis spores and vegetative bacteria (4). 
Using the CFU results, a definite difference was noted between the disposal 
method, especially between burning and doing nothing to the carcass.  Though the 
difference between burning and burying was not statistically significant, an inspection 
of the CFU count data reveals that the burned carcasses in Mexico did not produce 
any isolates and the burned carcasses in Nevada did produce a mean of 3 x 103 
CFU/ml.  This difference could be attributed to the time lapse between discovery of 
the carcass and burning.  The carcasses in Mexico were found within hours of death 
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and burned within hours of being found, and the Nevada cases were not discovered 
until the following day after death and then were not burned until the next day after 
discovery.   
The time lapse difference between these locations is probably caused by the 
difference in man power and regulations.  The ranch in Mexico has range riders who 
ride the pastures every day and know the cattle and their habits.  These range riders 
can tell where the cattle are within a few meters at any time of day.  This ranch also 
has the means and manpower available to burn carcasses immediately after they are 
found.  In Nevada there was only the ranch manager who was unable to continually 
check on the cattle.  When a dead cow was found, the ranch manager would have to 
call in the veterinarian who would send samples into the state diagnostic laboratory.  
If anthrax was confirmed, the state and federal veterinarians were contacted, and a 
decision had to be made on how to dispose of the carcass.  This would leave one to 
believe that our own bureaucracy is helping to contaminate the environment.   
5.2. Future Studies 
More studies need to be done involving isolates that have been genotyped with 
the same method.  Though there was no association noted between antimicrobial 
susceptibility and MLVA genotype, surely if more representatives of all 89 genotypes 
were tested, a pattern would emerge.   
The antimicrobial susceptibility study revealed that all isolates of a species are not 
alike and should not be judged so.  When testing the 25 isolates with doxycycline, 
two isolates did show resistance.  Unfortunately this could not be verified on retest 
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with the same lot of E-test strips of doxycycline and tetracycline as these two isolates 
where shown to be susceptible.  Upon inspection of the recently published B. 
anthracis genome and discussion with the author revealed that B. anthracis does 
carry the tetracycline resistance gene (14).   
Another issue associated with antimicrobial studies is beta-lactamase production.  
This, too, should be considered to verify if beta-lactamase production is associated 
with penicillin resistance in B. anthracis. 
An association was definitely demonstrated between the MLVA clusters and 
virulence in AVA vaccinated guinea pigs.  The virulence model used to compare the 
predicted and observed virulence of the isolates needs to be tested on a much wider 
dataset, such as the 89 genotypes as defined by MLVA (7).  Using animals that are 
unimmunized with a full representative dataset of the 89 genotypes would validate the 
model and cluster effect.   
Since these studies were performed, a new generation of technology has evolved 
capable of absolute quantitative PCR.  Verification of the chromosome and plasmid 
copy numbers is suggested using the primers and probes presented here and other 
primers that target different areas of the chromosome and plasmids.   
More samples from various locations utilizing various methods of carcass 
disposal are needed.  These samples should include surface and burial soil and 
miscellaneous environmental samples.  Background surface soil samples also need to 
be collected.  These samples would consist of random sites not associated with 
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anthrax carcasses.  These samples would provide insight into the question of the 
ubiquitous distribution of the B. anthracis organism.   
These sampling efforts will generate hundreds - if not thousands - of samples.  
The plating effort to ascertain B. anthracis isolate recovery is very labor intensive and 
requires trained personnel to select the probable Bacillus colonies.  The results would 
indicate that more isolate recovery is required.  A better and more streamlined 
procedure needs to be developed to determine spore viability.   
Adapting the methods, spore concentration, DNA extraction, and viability to 
robotic technology is suggested.  This would greatly reduce the personnel and labor 
involved, accelerate the laboratory process, and provide results quickly and 
efficiently. 
5.3. Conclusions 
The results of this research have contributed greatly to the knowledge base of B. 
anthracis.  Additions to the antimicrobial susceptibility database with genotype 
knowledge will possibly help with gene identification involved in resistance.  The 
virulence model is an important tool for the screening of isolates and vaccine testing.  
This is truly a paradigm in virulence testing.   
The methodologies and insights gained from the soil study have provided the 
background and direction needed to realize the importance of such studies.  They 
have provided an impetus to continue the effort of trying to understand the ecology 
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